Professor J. Paul Santerre has published >195 peer reviewed publications and is a listed inventor on >70 patents in the area of medical polymers, biodegradation, protein and blood interactions with surfaces, surface modification, regenerative medicine, and drug delivery. This research has led to the training of >70 graduate students, multiple postdoctoral fellows and >130 undergraduates, and >$50M CAD in grant funding. In addition to being a named fellow of many national and international academic bodies, he was co-founder and current director of the Health Innovation Hub at the University of Toronto. He is a co-founder of Interface Biologics (IBI) and current CSO for IBI and Ripple Therapeutics along with being and advisor to several other healthcare companies.
He has received several awards for his innovation and industry related activity including the Governor General’s award for Innovation and the Professional Engineers of Ontario Entrepreneurship Award in 2017. He is the Baxter Chair for Health Technology & Commercialization at the University Hospital Network, and was the recipient of the 2018 US Society for Biomaterials Clemson Award for contributions to the literature.